In 2016 Matteo Forloni et al. [52] demonstrated that EGFR triggered the silencing of multiple tumour suppressors in lung adenocarcinoma via C/EBPα transcription factor by inhibiting TET1 expression. This evidence concerns the gene TET1 and neoplasm.